首页 > 产品中心 > 抗体 > 一抗

Anti-Etanercept Idiotype Antibody (Non-Neutralizing) (ICH6070)

价格: --
规格:
  • 1mg
数量:
  • 概述

  • 图片

  • 参考文献

概述
货号ICH6070
品牌IchorBio
描述
Anti-Etanercept Idiotype Antibody (Non-Neutralizing) (ICH6070) is a Mouse (IgG2a kappa) antibody targeting Etanercept. Reactive with Human. Validated for ELISA, Western Blot, Immunohistochemistry.
Highlights
  • ●Low Endotoxin — Suitable for in vivo and functional studies.
  • ●High Purity — Minimal background for reliable results.
  • ●Validated Applications — Tested in ELISA, Western Blot, Immunohistochemistry.
种属反应性Human
应用ELISA, Western Blot, Immunohistochemistry
宿主Mouse
克隆类型Monoclonal
同种型IgG2a kappa
经测试应用ELISA, Western Blot, Immunohistochemistry
靶标Etanercept
特异性Mouse monoclonal non-neutralizing anti-etanercept antibody
内毒素水平<1 EU/mg
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
Accession号CAS: 185243-69-0
状态Liquid
保存溶液 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

运输Blue ice
产品使用信息
应用方法 稀释比例
EC50=39.36ng/ml
稳定性和存储Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
规格Size: 1mg
背景

This is a mouse monoclonal anti-idiotype antibody (IgG2a, kappa) raised against the biologic drug etanercept, recognising the idiotypic region of the etanercept molecule. It is a non-neutralising clone, meaning it binds etanercept without blocking the drug's TNF-binding activity, which makes it well suited to bridging or capture formats where total drug (free plus bound) must be measured. Validated for ELISA, Western blot and immunohistochemistry, it functions as a critical reagent for pharmacokinetic assays, anti-drug antibody (ADA) assay development, and bioanalytical characterisation of etanercept and its biosimilars. Supplied as a bulk, research-use-only reagent at low endotoxin, it is intended for assay building, calibration/standard curve work, positive-control and surrogate-ADA applications, and QC of biosimilar batches. Because etanercept is a human therapeutic fusion protein rather than a rodent cell-surface target, this reagent is used in vitro and in bioanalytical workflows rather than in animal dosing studies. Non-neutralising specificity is the key selling point for total-drug quantitation. Etanercept is a recombinant human fusion protein combining the extracellular ligand-binding domain of the p75 TNF receptor 2 (TNFR2/CD120b) with the Fc portion of human IgG1. It acts as a soluble decoy receptor, binding and neutralising both tumour necrosis factor alpha (TNF-alpha) and lymphotoxin-alpha (TNF-beta), thereby preventing their engagement of cell-surface TNF receptors and dampening downstream pro-inflammatory NF-kB and MAPK signalling. By sequestering these cytokines, etanercept reduces the inflammatory cascade that drives synovitis, joint destruction and other autoimmune pathology. Clinically it is used in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis and plaque psoriasis. The dimeric Fc scaffold gives it a prolonged serum half-life. As an anti-idiotype target, its unique receptor-domain fold provides the epitope this antibody recognises.

NoteFor research use only
Isotype ControlICH2245
图片
参考文献
公式
质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)
填写 质量、浓度、体积中的任意 2 项 + 分子量,自动计算未知值。
质量
=
浓度
×
体积
分子量 *
g/mol
公式
C₁ × V₁ = C₂ × V₂
填写 4 项中的任意 3 项,自动计算未知值。
母液
C₁ (起始浓度)
×
V₁ (起始体积)
=
工作液
C₂ (终浓度)
×
V₂ (终体积)

相关产品推荐